Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment-Interview

Medicinal Cannabis and the Psychiatric Patient: Clinical Harm vs Novel Treatment-Interview

In this interview, Dr. Diana Martinez addresses common clinical concerns regarding the use of cannabis among patients with psychiatric disorders. She discusses current research on the use of cannabis for various conditions, such as pain, depressive and anxiety disorders, and residual symptoms of schizophrenia, among others. Finally, she highlights the importance of discussing with patients health risks associated with cannabis use.

  • Provider:Medical Academy, LLC
  • Activity Link: https://psychopharmacologyinstitute.com/publication/medicinal-cannabis-and-the-psychiatric-patient-clinical-harm-vs-novel-treatment-interview-2681?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
  • Start Date: 2022-10-01 05:00:00
  • End Date: 2022-10-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Yes
  • Measured Outcome: Learner Performance
  • Provider Ship: Jointly Provided
  • Registration: Limited
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.